Drug interactions for the following drug(s)
Applies to: Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Fluticasone.
Applies to: Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet <> lubiprostone 0.024 MG Oral Capsule [Amitiza]
Trimethoprim may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Applies to: Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet <> Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Fluticasone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT <> Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 896019, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent], tty = SBD). Drug2 (rxcui = 896019, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent], tty = SBD). Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone. Drug1 is resolved to fluticasone, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone and Fluticasone propionate. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone. Drug1 is resolved to fluticasone propionate, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Fluticasone propionate and Fluticasone furoate. Drug1 is resolved to fluticasone furoate, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Fluticasone furoate and Fluticasone propionate.
Applies to: Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet <> lubiprostone 0.024 MG Oral Capsule [Amitiza]
Drug1 (rxcui = 198335, name = sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 617768, name = lubiprostone 0.024 MG Oral Capsule [Amitiza], tty = SBD). Drug1 is resolved to trimethoprim, Drug2 is resolved to lubiprostone and interaction asserted in DrugBank between Trimethoprim and Lubiprostone. Drug1 is resolved to sulfamethoxazole, Drug2 is resolved to lubiprostone and interaction asserted in DrugBank between Sulfamethoxazole and Lubiprostone.
Applies to: Sulfamethoxazole 800 MG / Trimethoprim 160 MG Oral Tablet <> Flovent Diskus 50 MCG/ACTUAT Dry Powder Inhaler, 60 ACTUAT
Drug1 (rxcui = 198335, name = sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 896019, name = 60 ACTUAT fluticasone propionate 0.05 MG/ACTUAT Dry Powder Inhaler [Flovent], tty = SBD). Drug1 is resolved to sulfamethoxazole, Drug2 is resolved to fluticasone and interaction asserted in DrugBank between Sulfamethoxazole and Fluticasone. Drug1 is resolved to sulfamethoxazole, Drug2 is resolved to fluticasone propionate and interaction asserted in DrugBank between Sulfamethoxazole and Fluticasone propionate. Drug1 is resolved to sulfamethoxazole, Drug2 is resolved to fluticasone furoate and interaction asserted in DrugBank between Sulfamethoxazole and Fluticasone furoate.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.